You are viewing: Germany Pharmaceutical Manufacturing Equipment Market analysis

The Germany Pharmaceutical Manufacturing Equipment Market was valued at $1738.4 Million in 2026 and projected to reach to $2702.1 Million by 2031, representing a compound annual growth rate of 7.6%. Germany's pharmaceutical manufacturing equipment market is poised for sustained growth through 2031, driven by increasing investments in automation, digitalization, and compliance with stringent EU regulations.

Germany Pharmaceutical Manufacturing Equipment Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Germany Pharmaceutical Manufacturing Equipment Market Trends and Insights

  • Valued at $1,738.4 million in 2026, Germany's market is projected to expand to $2,702.1 million by 2031, reflecting a compound annual growth rate of 7.6%.
  • This growth trajectory outpaces the global average, driven by Germany's established pharmaceutical manufacturing base, stringent regulatory standards, and investment in advanced production technologies. The German market benefits from the country's reputation for precision engineering and quality assurance in pharmaceutical production.
  • Germany's commitment to Industry 4.0 and digital transformation is accelerating adoption of automated and intelligent manufacturing equipment.
  • Between 2026 and 2031, Germany is expected to see increased demand for modular, flexible, and sustainable equipment solutions that align with both EU regulatory requirements and evolving industry standards. Key growth catalysts for Germany include rising biopharmaceutical production, expansion of contract manufacturing organizations (CMOs), and modernization of existing facilities to meet GMP compliance and environmental regulations.
  • Germany's strategic position within the European Union further strengthens its role as a manufacturing and innovation center for pharmaceutical equipment..

Key Market Statistics

  • CAGR (2026-2031) 7.6% CAGR
  • Market Size, 2026 ~USD 1738.4 Million
  • Forecast, 2031 ~USD 2702.1 Million
  • Country Germany

Germany Pharmaceutical Manufacturing Equipment Market Overview

Market Valuation Growth :

Germany's pharmaceutical manufacturing equipment market is valued at $1,738.4 million in 2026 and is projected to reach $2,702.1 million by 2031, demonstrating robust expansion within Europe's life sciences sector.

Above-Global Growth Rate :

With a CAGR of 7.6%, Germany's market growth significantly outpaces the global average of 6.2%, positioning the country as a high-growth pharmaceutical equipment hub in Europe.

Established Manufacturing Infrastructure :

Germany's strong pharmaceutical manufacturing base, supported by advanced technology adoption and regulatory excellence, creates sustained demand for specialized equipment and automation solutions.

European Market Leadership :

As a critical hub within Europe's life sciences infrastructure, Germany attracts significant investment in pharmaceutical manufacturing equipment, driven by stringent quality standards and innovation-focused manufacturers.

Germany Pharmaceutical Manufacturing Equipment Market Dynamics

  • The country's established pharmaceutical sector, combined with growing demand for advanced manufacturing technologies, supports the projected 7.6% CAGR.
  • Key growth drivers include the expansion of biologics production, adoption of Industry 4.0 technologies, and heightened focus on supply chain resilience post-pandemic. The German market benefits from strong government support for life sciences innovation and the presence of leading pharmaceutical manufacturers.
  • Continued investments in R&D facilities and manufacturing capacity upgrades will sustain equipment demand.
  • Additionally, Germany's role as a European regulatory center and its commitment to sustainable manufacturing practices position it favorably for long-term market expansion and technological advancement in pharmaceutical equipment solutions..

Related Ecosystem

Industrial Automation

Top Technologies
  • Sensors
  • Image Sensors
  • Manufacturing Execution System (MES)
  • Actuators
  • Flow Sensors
Top Companies
  • Siemens ag
  • ABB India Limited
  • Emerson Electric Co.
  • HONEYWELL INTERNATIONAL INC.
  • SCHNEIDER ELECTRIC SE

    Key Takeaways

    • Germany's pharmaceutical manufacturing equipment market will grow from $1,738.4M (2026) to $2,702.1M (2031) at a 7.6% CAGR, outpacing global growth rates.
    • Germany's advanced engineering capabilities and Industry 4.0 initiatives are driving adoption of automated and digitally integrated manufacturing solutions.
    • Biopharmaceutical production expansion and CMO growth are key demand drivers for specialized equipment in Germany.
    • Germany's strict EU regulatory environment and GMP compliance requirements create sustained demand for high-quality, precision manufacturing equipment.

    Pharmaceutical Manufacturing Equipment Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment PACKAGING MACHINES (Equipment Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.2% from 2026 to 2031
    Largest Segment AUTOMATIC (Technology)
    Market Size Base Year (Billions) ~USD 21.18 (2026)
    Revenue Forecast (Billions) ~USD 28.62 (2031)
    Segments Covered Equipment Type, End-Product Type, Technology

    Germany Pharmaceutical Manufacturing Equipment Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Equipment Type

    • Extrusion Equipment
    • Filling Machines
    • Granulation Equipment
    • Inspection Equipment
    • Milling Equipment
    • Mixing & Blending Machines
    • Packaging Machines
    • Spray Drying Equipment
    • Sterilization Equipment
    • Tablet Compression Presses

    By End-Product Type

    • Liquid
    • Solid

    By Technology

    • Automatic
    • Semi-Automatic

    Target Audience

    • Pharmaceutical Equipment Manufacturers : Manufacturers need Germany-specific market data to optimize product development, pricing strategies, and distribution channels within Europe's most advanced pharmaceutical equipment market.
    • Pharmaceutical Companies & Contract Manufacturers : German and European pharma producers require detailed market insights to plan capital equipment investments, upgrade manufacturing facilities, and maintain competitive production capabilities.
    • Private Equity & Investment Firms : Investors targeting the German life sciences sector need comprehensive market analysis to evaluate acquisition targets, assess growth potential, and identify high-return investment opportunities.
    • Equipment Distributors & System Integrators : German and European distributors require market forecasts and segment analysis to optimize inventory, develop customer solutions, and capture growth in automation and digitalization trends.
    • Government & Industry Organizations : German regulatory bodies, industry associations, and policy makers need market intelligence to support life sciences strategy, funding decisions, and competitive positioning within Europe.

    Key Companies in the Germany Pharmaceutical Manufacturing Equipment Market

    CompanyHQOwnershipStrongest segments
    GEA GROUP AKTIENGESELLSCHAFTUnited StatesPublic CompanySeparation & Flow Technologies,Liquid & Power Technologies,Food & Health Technologies,
    KöRBER AGGermanyPrivate CompanySupply chain software, automation, voice, robotics, and material handling,Pharma machinery, equipment, and related software,Technologies: measuring instruments, flavors, food and beverage, and e-mobility equipment,
    IMA INDUSTRIA MACCHINE AUTOMATICHE SPAItalyPrivate CompanyPharmaceutical processing and packaging systems,Food, dairy, and beverage packaging lines,Tea, coffee, and related portioning systems,
    ACGBermudaPublic CompanyInsurance,Reinsurance,Mortgage,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    ELIZABETH COMPANIESUnited StatesPrivate CompanyPrestige and heritage fragrances,Licensed designer and celebrity fragrances,Skincare (Elizabeth Arden, Ceramide, Prevage, Eight Hour, Pro),
    FREUNDJapanPrivate CompanyPharmaceutical granulation and coating equipment,Plant engineering and integrated systems,Pharmaceutical excipients,

    GEA GROUP AKTIENGESELLSCHAFT

    GEA GROUP AKTIENGESELLSCHAFT is a publicly traded company founded in 1881 with 19,670 employees operating in the United States.

    KöRBER AG

    KÖRBER AG is a German private company founded in 1946 with 10,665 employees.

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA is an Italian private company founded in 1961 with 6,121 employees.

    ACG

    ACG is a publicly traded company based in Bermuda founded in 1995 with 8,000 employees.

    THERMO FISHER SCIENTIFIC INC.

    THERMO FISHER SCIENTIFIC INC. is a publicly traded United States company founded in 1956 with 125,000 employees.

    ELIZABETH COMPANIES

    ELIZABETH COMPANIES is a United States-based private company founded in 1910 with 2,150 employees.

    FREUND

    FREUND is a Japan-based private company founded in 1964 with 427 employees.

    Reasons to Buy this Report

    • Market-Specific Growth Intelligence : Gain detailed insights into Germany's 7.6% CAGR trajectory, significantly outpacing global averages, enabling informed investment and expansion decisions within Europe's strongest pharmaceutical equipment market.
    • Competitive Landscape Analysis : Understand Germany's established manufacturing infrastructure, regulatory environment, and technology adoption patterns to identify competitive advantages and market positioning opportunities for equipment suppliers.
    • Forecast-Driven Strategic Planning : Leverage precise market projections from $1,738.4M (2026) to $2,702.1M (2031) to develop targeted go-to-market strategies and resource allocation plans specific to German pharmaceutical manufacturers.
    • Regulatory & Compliance Insights : Access Germany-specific regulatory requirements, EU compliance standards, and quality benchmarks that directly influence equipment specifications, purchasing decisions, and supplier selection criteria.
    • Investment & Partnership Opportunities : Identify high-growth segments, emerging technologies, and strategic partnership opportunities within Germany's life sciences hub to maximize ROI and establish long-term market presence.

    Frequently asked questions

    What is the current size of Germany's pharmaceutical manufacturing equipment market?

    Germany's pharmaceutical manufacturing equipment market is valued at $1,738.4 million in 2026 and is projected to reach $2,702.1 million by 2031.

    What is the expected growth rate for Germany's pharmaceutical manufacturing equipment market?

    Germany's market is expected to grow at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2031.

    What are the main drivers of growth in Germany's pharmaceutical manufacturing equipment market?

    Key drivers include biopharmaceutical production expansion, contract manufacturing organization (CMO) growth, Industry 4.0 digital transformation, and modernization of facilities to meet GMP and environmental regulations.

    How does Germany's market growth compare to global trends?

    Germany's 7.6% CAGR outpaces the global pharmaceutical manufacturing equipment market CAGR of 6.2%, reflecting Germany's strong position in advanced manufacturing and life sciences.

    What types of equipment are in demand in Germany's pharmaceutical manufacturing sector?

    Germany shows strong demand for automated, modular, flexible, and sustainable equipment solutions that comply with EU regulatory standards and support Industry 4.0 integration.

    RESEARCH METHODOLOGY

    The research process for this study involved the systematic gathering, recording, and analysis of data on customers and companies operating in the pharmaceutical manufacturing equipment market. This process involved the extensive use of secondary sources, directories, and databases (Factiva and Oanda) to identify and collect valuable information for the comprehensive, technical, market-oriented, and commercial study of the pharmaceutical manufacturing equipment market. In-depth interviews were conducted with primary respondents, including experts from core and related industries, as well as preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess growth prospects. Key players in the pharmaceutical manufacturing equipment market were identified through secondary research, and their market rankings were determined through a combination of primary and secondary research. This research involved studying the annual reports of top players and conducting interviews with key industry experts, including CEOs, directors, and marketing executives.

    Secondary Research

    Various sources were utilized in the secondary research process to identify and collect information relevant to this study. These include company annual reports, press releases, investor presentations, white papers, technology journals, certified publications, articles by recognized authors, directories, and databases. Secondary research was primarily used to gather key information about the industry’s value chain, the total pool of market players, market classification according to industry trends at the most detailed level, regional markets, and key developments from both market and technology-oriented perspectives.

    Primary Research

    Primary research was conducted to identify the segmentation types, key players, competitive landscape, and key market dynamics, including drivers, restraints, opportunities, challenges, and industry trends, as well as key strategies adopted by players operating in the pharmaceutical manufacturing equipment market. Extensive qualitative and quantitative analyses were performed on the complete market engineering process to list key information and insights throughout the report.
    Extensive primary research has been conducted after gaining insights into the pharmaceutical manufacturing equipment market scenarios through secondary research. Several primary interviews were conducted with experts from the demand (region) and supply side (equipment type, end-product type, and technology) across four major geographic regions: North America, Europe, Asia Pacific, and RoW. Approximately 60% and 40% of the primary interviews were conducted from the supply and demand sides, respectively. These primary data have been collected through questionnaires, emails, and telephonic interviews.

    Pharmaceutical Manufacturing Equipment Market Size, and Share

    Notes: The three tiers of companies have been defined based on their total/segmental revenue as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million–USD 1 billion, and Tier 3 = <USD 500 million.
    Other designations include sales, marketing, and product managers.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods were implemented to estimate and validate the size of the pharmaceutical manufacturing equipment market and various other dependent submarkets. Key players were identified through secondary research, and their market share in the respective regions was determined through a combination of primary and secondary research. This entire research methodology involved studying the annual and financial reports of the top players, as well as conducting interviews with experts (CEOs, VPs, directors, and marketing executives) to gather key insights (both quantitative and qualitative).

    All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Pharmaceutical Manufacturing Equipment Market : Top-Down and Bottom-Up Approach

    Pharmaceutical Manufacturing Equipment Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size through the estimation process, as explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, market breakdown and data triangulation procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market has been validated using both top-down and bottom-up approaches.

    Market Definition

    The pharmaceutical manufacturing equipment market covers the global ecosystem involved in the development, production, processing, and packaging of pharmaceutical products across solid and liquid formulations. It includes machinery and integrated systems designed to ensure precision and sterility. These systems maintain regulatory compliance and operational efficiency. Equipment supports activities from raw material handling to final packaging. Manufacturers use these systems to maintain product quality. Large-scale and contract facilities rely on advanced machinery to optimize throughput.

    The pharmaceutical manufacturing equipment market is segmented by equipment type, such as packaging machines and filling machines. Spray drying equipment and mixing & blending machines are also included. Milling equipment and extrusion equipment support formulation processes. Tablet compression presses and inspection equipment ensure quality control. Granulation and sterilization equipment are also key categories. By end-product type, the market includes solid and liquid formulations. By technology, the market consists of semi-automatic and automatic systems. Automation improves productivity and reduces manual intervention. Growing pharmaceutical production supports equipment demand. Expansion of biologics and generics manufacturing drives modernization. Investment in advanced manufacturing technologies strengthens global market growth.

    Key Stakeholders

    • Pharmaceutical manufacturing equipment manufacturers
    • End users
    • Automation consultants
    • Research organizations
    • Technology investors
    • Technology standards organizations, forums, alliances, and associations
    • Process automation and instrumentation solution and product suppliers
    • Instrumentation and automation products’ original equipment manufacturers (OEMs)
    • Energy industry associations

    Report Objectives

    • To describe and forecast the pharmaceutical manufacturing equipment market, by equipment type, end-product type, and technology, in terms of value
    • To forecast the market size for four key regions, namely North America, Europe, Asia Pacific, and the Rest of the World (RoW), along with their country-level analyses, in terms of value
    • To estimate the market size, by equipment type, in terms of volume
    • To provide detailed information regarding the major factors influencing the growth of the market, namely, drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
    • To study the complete value chain of the pharmaceutical manufacturing equipment ecosystem, along with market trends and use cases
    • To analyze opportunities for stakeholders in the market by identifying high-growth segments of the market
    • To strategically profile key players and comprehensively analyze their core competencies2, along with detailing the competitive landscape for market leaders
    • To analyze competitive developments, such as product launches, mergers, acquisitions, partnerships, collaborations, and expansions, in the pharmaceutical manufacturing equipment market.
    • To benchmark market players using the company evaluation matrix, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide information on Porter’s five forces analysis, pricing analysis, trade analysis, investment and funding scenario, key conferences and events, regulatory landscape, ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs of various equipment types, interconnected markets and cross-sector opportunities, macroeconomic outlook, and the impact of AI, and the impact of 2025 US tariff
    • To benchmark market players using the company evaluation quadrant, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide a macroeconomic outlook for all regions covered in this report
    • To provide information on ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs from various applications, interconnected markets, and cross-sector opportunities, and the impact of AI and its use cases, and the 2025 US tariff impact

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

     

    Get the Full Pharmaceutical Manufacturing Equipment Market Report

    Full forecast, segment splits, and company analysis for all Pharmaceutical Manufacturing Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status